Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study | Zendy

Frédérique Maire | Zendy; Catherine LombardBohas | Zendy; Dermot O’Toole | Zendy; MariePierre Vullierme | Zendy; Vinciane Rebours | Zendy; Anne Couvelard | Zendy; Anne Laure Pelletier | Zendy; Magaly Zappa | Zendy; F. Pilleul | Zendy; Olivia Hentic | Zendy; Pascal Hammel | Zendy; Philippe Ruszniewski | Zendy

Open Access

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

Author(s) -

Frédérique Maire,

Catherine LombardBohas,

Dermot O’Toole,

MariePierre Vullierme,

Vinciane Rebours,

Anne Couvelard,

Anne Laure Pelletier,

Magaly Zappa,

F. Pilleul,

Olivia Hentic,

Pascal Hammel,

Philippe Ruszniewski

Publication year - 2012

Publication title -

neuroendocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.493

H-Index - 101

eISSN - 1423-0194

pISSN - 0028-3835

DOI - 10.1159/000336941

Subject(s) - medicine , gastroenterology , clinical endpoint , urology , neuroendocrine tumors , chemotherapy , embolization , endocrine system , chromogranin a , metastasis , surgery , endocrinology , randomized controlled trial , cancer , hormone , immunohistochemistry

Liver surgery is the best treatment for endocrine liver metastases, but it is often impossible due to diffuse disease. Systemic chemotherapy is poorly effective. Hepatic arterial embolization (HAE) and chemoembolization (HACE) have shown efficacy but have never been compared.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research